How Do I Become a Pharmaceutical Engineer?
Wang Deqin, senior pharmaceutical engineer, member of the Communist Party of China, is currently the deputy general manager of Guangzhou Baiyunshan Hutchison Whampoa Traditional Chinese Medicine Co., Ltd., the director of the Office of Science and Technology Innovation, and the first deputy dean of the Modern Chinese Medicine Research Institute. jobs. Since 2006, she has participated in the establishment and implementation of more than 30 scientific research, technological transformation and science popularization projects in relevant national, provincial, and municipal departments, including the secondary development of famous Chinese patent medicines, the construction of GAP research and industrialization bases for Chinese medicinal materials, Research and development of new Chinese medicines, development of health products, technological transformation of GMP, and construction of science popularization bases. His research results on related topics have won 5 invention patents and 1 utility model patent; published more than 10 papers; won 1 provincial scientific and technological progress second prize, 2 third prizes, and 3 municipal scientific and technological progress awards. Three prizes for medical science and technology progress, one provincial excellent new product award, and two provincial management innovation achievement awards. [1]
Wang Deqin
(Senior Pharmaceutical Engineer)
- Wang Deqin, female, born in February 1969,
- Wang Deqin, senior pharmaceutical engineer, member of the Communist Party of China, is currently the deputy general manager of Guangzhou Baiyunshan Hutchison Whampoa Traditional Chinese Medicine Co., Ltd., the director of the Office of Science and Technology Innovation, and the first deputy dean of the Modern Chinese Medicine Research Institute. jobs. Since 2006, she has participated in the establishment and implementation of more than 30 scientific research, technological transformation and science popularization projects in relevant national, provincial, and municipal departments, including the secondary development of famous Chinese patent medicines, the construction of GAP research and industrialization bases for Chinese medicinal materials, Research and development of new Chinese medicines, development of health products, technological transformation of GMP, and construction of science popularization bases. His research results on related topics have won 5 invention patents and 1 utility model patent; published more than 10 papers; won 1 provincial scientific and technological progress second prize, 2 third prizes, and 3 municipal scientific and technological progress awards. Three prizes for medical science and technology progress, one provincial excellent new product award, and two provincial management innovation achievement awards. [1]
- In early 2006, Guangzhou Baiyunshan Hutchison Whampoa Traditional Chinese Medicine Co., Ltd. actively responded to the call of the Party Central Committee, the State Council, the Provincial Party Committee and the Provincial Government, and established the independent innovation strategy as the leading development strategy of the enterprise. Under the direct leadership and command of General Manager Li Chuyuan, the general manager of the company, Comrade Wang Deqin accelerated the pace of establishment and improvement of the company's independent technological innovation system. The Enterprise Technology Center was recognized by the Guangdong Provincial Enterprise Technology Center in March 2006. At the end of the year, the company was selected as "the first batch of independent innovation pilot enterprises in Guangdong Province." In 2007, in order to further strengthen the research and development and the construction of the results transformation platform, Comrade Wang Deqin led the backbone of scientific research to actively build the "Guangzhou Key Engineering Technology R & D Center". In September 2007, the project was supported by the Guangzhou Science and Technology Bureau. At the same time, the company proposed The goal of "sci-tech innovation sprinting to the national team" was achieved. Comrade Wang Deqin led the entire staff of the Institute and the Innovation Office. With the cooperation of other departments of the company, after more than a year of hard work, the company's technological innovation system construction made breakthrough progress in 2008: in mid-June 2008, The Ministry of Human Resources and Social Security approved the establishment of an enterprise post-doctoral scientific research workstation; at the end of June, 29 enterprises including Baiyunshan and Huang Chinese Medicine were successfully selected into the first batch of "Guangdong Innovative Enterprises" by the six ministries and commissions such as the Provincial Department of Science and Technology. The only pharmaceutical company among them; in August 2008, in recognition of its achievements in introducing new technologies, new processes and new equipment to enhance its core competitiveness and effective protection of related products and core technological achievements, The Intellectual Property Office was rated as "Guangdong Provincial Intellectual Property Advantage Enterprise". At the end of 2008, the first batch of enterprises was recognized as a national high-tech enterprise. As a result, the company established a national-provincial-municipal three-level scientific and technological innovation platform, which has become a strong and large-scale technological innovation carrier in the industry and a strong sustainable development enterprise. Innovation engine. [2]
- The subject of scientific and technological innovation is the essence of modern enterprises, and it is also an important feature of the transformation of modern scientific and technological development models. However, the scientific and technological innovation model has no ready-made experience for the traditional Chinese medicine industry. On the road of exploring the scientific and technological innovation model, Comrade Wang Deqin undertook the guidance of the company's directors to carry out a bold combination of the company's actual situation. explore. While Guangzhou Pharmaceutical Group Baiyunshan Co., Ltd. and Hutchison Whampoa Enterprises, the richest man in the Chinese family, established Hutchison Whampoa Chinese Medicine Co., Ltd. in Guangzhou, in May 2005, the company took the lead in setting up Baiyunshan, the largest enterprise research institute in South China. Under the direct leadership of Hutchison Whampoa Institute of Modern Chinese Medicine, the company's general manager Li Chuyuan served as the dean, and Comrade Wang Deqin served as the first deputy. Under the direct leadership of the company, the company gradually established its own technological innovation model in practice. More than 30 domestic universities, research institutes and research institutions have established scientific research cooperation relationships, and established an efficient, interactive platform for industry-university-research cooperation. On October 23, 2007, with an open mind, the cooperation with the National Key Laboratory of Respiratory Diseases led by Academician Zhong Nanshan was jointly established and formally signed for implementation, creating a precedent for enterprises to participate in the co-construction of the National Key Laboratory; 2008 In July, Comrade Wang Deqin went to Tianjin with the company s human resources leader to contact Tianjin to introduce Academician Liu Changxiao. After a period of communication and liaison, on February 7, 2009, Liu Changxiao, a well-known pharmacokinetics expert and academician of the Chinese Academy of Engineering, formally He joined Baiyunshan and Huang as the dean of the Modern Chinese Medicine Research Institute and became the first academician in Guangdong to enter the enterprise after implementing the "Opinions on Accelerating the Cultivation of High-level Talents" strategy.
- In order to accelerate the big medicine strategy of promoting enterprises through science and technology, Comrade Wang Deqin can unite and lead the scientific and technological personnel in the company, and follow the three guiding principles established by the company, namely, market, cutting-edge technology and government policies, to comprehensively improve The company's scientific and technological innovation capabilities and market competitiveness are the goals. With the company as the main body, it continuously integrates external superior technology and human resources. Through the organization and implementation of a number of major scientific research projects, it strives to improve the company's three innovative capabilities, namely, "independent innovation capabilities." , The ability to integrate resources and the ability to respond quickly to the market, "so that scientific and technological innovation has become one of the three core competitiveness of enterprises.
- A good culture of innovation has a positive role in stimulating and cultivating innovative thinking, creating innovative talents, making innovative achievements, and achieving sustainable development, and is the basis for the smooth progress of independent innovation strategies. As the technology leader of the enterprise, Comrade Wang Deqin deeply feels the important role of innovation culture. In the scientific research and development and technology management departments, he strives to create a cultural atmosphere of "exploration and innovation, forge ahead, unity and cooperation, and performance-oriented". Failure to maintain a correct attitude, and strive to create a relaxed environment that "encourages success and tolerate failure," thereby inspiring the entire scientific and technological team's enthusiasm for innovation and creativity. [1]
- The content of Baidu Encyclopedia is edited by netizens. If you find your entry is inaccurate or incomplete, you are welcome to use my entry editing service (free of charge) to participate in the correction. Go Now >>